A Single‑Center Retrospective Cohort Study: Impact of Glycemic Control on First‑Line TKI Plus PD‑1 Inhibitors versus TKI Alone in Intermediate‑to‑advanced Unresectable Hepatocellular Carcinoma(HCC) with Type 2 Diabetes Mellitus (T2DM)
{{output}}
Background and aim: Type 2 diabetes mellitus (T2DM) is an independent risk factor for hepatocellular carcinoma (HCC), and the number of HCC patients with comorbid T2DM is increasing. Although tyrosine kinase inhibitor (TKI) monot... ...
